FDA approves galantamine for Alzheimer's disease.
Thompson
C A
CA
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D017277:Drug Approval; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D014481:United States; D014486:United States Food and Drug Administration
D002800:Cholinesterase Inhibitors; D005702:Galantamine